Terms: = Breast cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
22 results:
1. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.
Cui M; Dong H; Duan W; Wang X; Liu Y; Shi L; Zhang B
PeerJ; 2024; 12():e16958. PubMed ID: 38410801
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative breast cancer.
Limsakul P; Choochuen P; Jungrungrueang T; Charupanit K
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338684
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of stromal pdgfr-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients.
Akanda MR; Ahn EJ; Kim YJ; Salam SMA; Noh MG; Lee TK; Kim SS; Lee KH; Moon KS
BMC Cancer; 2023 May; 23(1):468. PubMed ID: 37217880
[TBL] [Abstract] [Full Text] [Related]
4. Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation.
Tang YH; Rockstroh A; Sokolowski KA; Lynam LR; Lehman M; Thompson EW; Gregory PA; Nelson CC; Volpert M; Hollier BG
Breast Cancer Res; 2022 Jan; 24(1):8. PubMed ID: 35078508
[TBL] [Abstract] [Full Text] [Related]
5. pdgfr-β
Hu G; Huang L; Zhong K; Meng L; Xu F; Wang S; Zhang T
Aging (Albany NY); 2021 May; 13(10):13693-13707. PubMed ID: 33946048
[TBL] [Abstract] [Full Text] [Related]
6. Gain of HIF1 Activity and Loss of miRNA
Wyss CB; Duffey N; Peyvandi S; Barras D; Martinez Usatorre A; Coquoz O; Romero P; Delorenzi M; Lorusso G; Rüegg C
Cancer Res; 2021 Feb; 81(3):594-605. PubMed ID: 33526470
[TBL] [Abstract] [Full Text] [Related]
7. Broadening Drug Design and Targets to Tumor Microenvironment? cancer-Associated Fibroblast Marker Expression in cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of docetaxel chemosensitivity by NR2F6 in breast cancer.
Zhang J; Meng H; Zhang M; Zhang C; Huang M; Yan C; Wang Z; Hou L; Yang L; Ling R
Endocr Relat Cancer; 2020 May; 27(5):309-323. PubMed ID: 32203934
[TBL] [Abstract] [Full Text] [Related]
9. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
Strell C; Paulsson J; Jin SB; Tobin NP; Mezheyeuski A; Roswall P; Mutgan C; Mitsios N; Johansson H; Wickberg SM; Svedlund J; Nilsson M; Hall P; Mulder J; Radisky DC; Pietras K; Bergh J; Lendahl U; Wärnberg F; Östman A
J Natl Cancer Inst; 2019 Sep; 111(9):983-995. PubMed ID: 30816935
[TBL] [Abstract] [Full Text] [Related]
10. Design, synthesis and structure-activity relationship studies of a focused library of pyrimidine moiety with anti-proliferative and anti-metastasis activities in triple negative breast cancer.
Yao D; Zhou Y; Zhu L; Ouyang L; Zhang J; Jiang Y; Zhao Y; Sun D; Yang S; Yu Y; Wang J
Eur J Med Chem; 2017 Nov; 140():155-171. PubMed ID: 28923383
[TBL] [Abstract] [Full Text] [Related]
11. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract] [Full Text] [Related]
12. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract] [Full Text] [Related]
13. Impact of p53 and pdgfr-β Expression on Metastasis and prognosis of Patients with Pancreatic cancer.
Kurahara H; Maemura K; Mataki Y; Sakoda M; Shinchi H; Natsugoe S
World J Surg; 2016 Aug; 40(8):1977-84. PubMed ID: 26940582
[TBL] [Abstract] [Full Text] [Related]
14. PDGF receptors in tumor biology: prognostic and predictive potential.
Paulsson J; Ehnman M; Östman A
Future Oncol; 2014; 10(9):1695-708. PubMed ID: 25145436
[TBL] [Abstract] [Full Text] [Related]
15. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
[TBL] [Abstract] [Full Text] [Related]
16. pdgfrβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells.
Plantamura I; Casalini P; Dugnani E; Sasso M; D'Ippolito E; Tortoreto M; Cacciatore M; Guarnotta C; Ghirelli C; Barajon I; Bianchi F; Triulzi T; Agresti R; Balsari A; Campiglio M; Tripodo C; Iorio MV; Tagliabue E
Mol Oncol; 2014 Jul; 8(5):968-81. PubMed ID: 24747080
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic relevance of cancer-associated fibroblasts in human cancer.
Paulsson J; Micke P
Semin Cancer Biol; 2014 Apr; 25():61-8. PubMed ID: 24560651
[TBL] [Abstract] [Full Text] [Related]
18. Radiation-induced senescence in securin-deficient cancer cells promotes cell invasion involving the IL-6/STAT3 and PDGF-BB/pdgfr pathways.
Yu YC; Yang PM; Chuah QY; Huang YH; Peng CW; Lee YJ; Chiu SJ
Sci Rep; 2013; 3():1675. PubMed ID: 23591770
[TBL] [Abstract] [Full Text] [Related]
19. A distinct spectrum of copy number aberrations in pediatric high-grade gliomas.
Bax DA; Mackay A; Little SE; Carvalho D; Viana-Pereira M; Tamber N; Grigoriadis AE; Ashworth A; Reis RM; Ellison DW; Al-Sarraj S; Hargrave D; Jones C
Clin Cancer Res; 2010 Jul; 16(13):3368-77. PubMed ID: 20570930
[TBL] [Abstract] [Full Text] [Related]
20. A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours.
Wolf D; Rumpold H
Drug Saf; 2009; 32(11):1001-15. PubMed ID: 19810774
[TBL] [Abstract] [Full Text] [Related]
[Next]
